Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Carmel Medical Center
• Treatments: Remifentanil; Ropivacaine

Criteria

Inclusion Criteria:

• Elective gynecological laparoscopic surgery including unilateral or bilateral salpingo-oophorectomy or ovarian cystectomy

• Patient not participating in other medical study at present or during the last 30 days

• Patient is capable of reading, understanding and signing on an informed consent

• Age 18 years and above

• ASA physical status grade 1-2

Exclusion Criteria:

• Allergy to ropivacaine or other local anesthetics or other medications listed in the protocol

• Acute pelvic inflammatory disease

• Coumadin or aspirin treatment

• Significant arrythmias

• Analgesic treatment for chronic pain

• BMI>35